Lazard Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26
| Closed | – | – | 2385 |
|
|
2024
Q4 | $0 | Hold |
26
| – | – | ﹤0.01% | 2360 |
|
|
2024
Q3 | $0 | Sell |
26
-64
| -71% | – | ﹤0.01% | 2318 |
|
|
2024
Q2 | $1K | Sell |
90
-1,443
| -94% | -$16K | ﹤0.01% | 2142 |
|
|
2024
Q1 | $48K | Sell |
1,533
-7,981
| -84% | -$250K | ﹤0.01% | 1722 |
|
|
2023
Q4 | $192K | Buy |
9,514
+7,221
| +315% | +$146K | ﹤0.01% | 1397 |
|
|
2023
Q3 | $28K | Buy |
2,293
+103
| +5% | +$1.26K | ﹤0.01% | 2043 |
|
|
2023
Q2 | $38K | Buy |
2,190
+671
| +44% | +$11.6K | ﹤0.01% | 1913 |
|
|
2023
Q1 | $25K | Sell |
1,519
-660
| -30% | -$10.9K | ﹤0.01% | 1999 |
|
|
2022
Q4 | $48K | Buy |
+2,179
| New | +$48K | ﹤0.01% | 1836 |
|